UK

Prior information notice

Information

Published

Expire date: 31/01/2022

External Reference: 2021-503859

FTS Reference: 2021-029604

Prior information notice

Prior information notice

Services

This notice is for prior information only

Section I: Contracting authority

I.1)

Name and addresses

Bristol & Weston NHS Purchasing Consortium
Princess Campbell Office
Bristol
BS10 5NB
UK
Contact person: BWPC Lukas Mokrolusky
Telephone: +44 1174142681
E-mail: lukas.mokrolusky@nbt.nhs.uk
NUTS code:  UKK11 -  Bristol, City of
Internet address(es):
Main address: http://nww.bwpc.nhs.uk/Default.htm

I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:  
https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=41045&B=NHSSW
Additional information can be obtained from
the abovementioned address:  
I.4)

Type of the contracting authority

Regional or local authority
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Outpatient Dispensing Pharmacy (ODP) and associated services
Reference number:  BWPCCL0001538
II.1.2)

Main CPV code

85149000  -  Pharmacy services
II.1.3)

Type of contract

Services
II.1.4)

Short description

This notice is published for the purpose of early market engagement only and is not intended as a call for competition. Bristol & Weston NHS Purchasing Consortium (BWPC) are seeking to engage with the market to understand the suppliers who may be interested in participating in the tender.
The Trust are seeking to select a partner to provide an outsourced outpatient pharmacy dispensing service, including oral chemotherapy, antiviral treatment of hepatitis C, and compliance aids. Selected supplier will be required to provide the services in Bristol Royal Infirmary and Weston General Hospital.
The contractor will be responsible for the procurement, storage, dispensing, distribution and delivery of outpatient and day case medicines (including oral chemotherapy, antiviral treatment of hepatitis C) and provide a compliance aid service for the Trusts inpatients on discharge.
II.1.5)

Estimated total value

Value excluding VAT: 10000000.00  GBP
II.1.6)

Information about lots

This contract is divided into lots: no
II.2)

Description

II.2.2)

Additional CPV code(s)

85149000  -  Pharmacy services
II.2.3)

Place of performance

NUTS code:  UK -  UNITED KINGDOM
II.2.4)

Description of the procurement

This notice is published for the purpose of early market engagement only and is not intended as a call for competition. Bristol & Weston NHS Purchasing Consortium (BWPC) are seeking to engage with the market to understand the suppliers who may be interested in participating in the tender.
The Trust are seeking to select a partner to provide an outsourced outpatient pharmacy dispensing service, including oral chemotherapy, antiviral treatment of hepatitis C, and compliance aids. Selected supplier will be required to provide the services in Bristol Royal Infirmary and Weston General Hospital.
The contractor will be responsible for the procurement, storage, dispensing, distribution and delivery of outpatient and day case medicines (including oral chemotherapy, antiviral treatment of hepatitis C) and provide a compliance aid service for the Trusts inpatients on discharge.
II.3)

Estimated date of publication of contract notice:

01/03/2022

Section IV: Procedure

IV.1)

Description

IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : no
IV.2)

Administrative information

Section VI: Complementary information

VI.3)

Additional information

This notice is published for the purpose of early market engagement only. For the avoidance of doubt, this market consultation exercise implies no commercial commitment and is not a formal tender process. The information gathered will be used in the planning and conduct of any future procurement process, as well as developing the scope and specification of the requirement.
Following receipt of expressions of interest the project team will subsequently make arrangements for the next steps of the market engagement process.